This statistic depicts small molecules sales at risk due to patent expirations in the U.S. from 2014 to 2023. According to the data, in 2018, 8.3 billion U.S. dollars were at risk due to loss of exclusivity.
Small molecules sales at risk due to patent expirations in the U.S. from 2014 to 2023
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Association for Accessible Medicines, & IQVIA. (February 5, 2019). Small molecules sales at risk due to patent expirations in the U.S. from 2014 to 2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/869784/projected-sales-at-risk-due-to-loss-of-exclusivity/
Association for Accessible Medicines, und IQVIA. "Small molecules sales at risk due to patent expirations in the U.S. from 2014 to 2023 (in billion U.S. dollars)." Chart. February 5, 2019. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/869784/projected-sales-at-risk-due-to-loss-of-exclusivity/
Association for Accessible Medicines, IQVIA. (2019). Small molecules sales at risk due to patent expirations in the U.S. from 2014 to 2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/869784/projected-sales-at-risk-due-to-loss-of-exclusivity/
Association for Accessible Medicines, and IQVIA. "Small Molecules Sales at Risk Due to Patent Expirations in The U.S. from 2014 to 2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 5 Feb 2019, https://www-statista-com.ezproxy.canberra.edu.au/statistics/869784/projected-sales-at-risk-due-to-loss-of-exclusivity/
Association for Accessible Medicines & IQVIA, Small molecules sales at risk due to patent expirations in the U.S. from 2014 to 2023 (in billion U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/869784/projected-sales-at-risk-due-to-loss-of-exclusivity/ (last visited November 10, 2024)
Small molecules sales at risk due to patent expirations in the U.S. from 2014 to 2023 (in billion U.S. dollars) [Graph], Association for Accessible Medicines, & IQVIA, February 5, 2019. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/869784/projected-sales-at-risk-due-to-loss-of-exclusivity/
